A novel mechanism of antibody-mediated enhancement of flavivirus infection

PLoS Pathogens

Volumn 13, Issue 9, 2017, Pages

  Haslwanter, Denise ^a   Blaas, Dieter ^b   Heinz, Franz X ^a   Stiasny, Karin ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY RESPONSE; ARTICLE; CELL MEMBRANE; CROSS LINKING; ENDOCYTOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLAVIVIRUS INFECTION; HUMAN; IMMUNOASSAY; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; VIROGENESIS; VIRUS ATTACHMENT; VIRUS INFECTIVITY; ANTIBODY DEPENDENT ENHANCEMENT; FLAVIVIRUS; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; TICK BORNE ENCEPHALITIS VIRUS; VIROLOGY;

LIPOSOME; MONOCLONAL ANTIBODY; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIBODY-DEPENDENT ENHANCEMENT; ENCEPHALITIS VIRUSES, TICK-BORNE; FLAVIVIRUS; FLAVIVIRUS INFECTIONS; HUMANS; LIPOSOMES; VIRAL ENVELOPE PROTEINS;

EID: 85030455683     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1006643     Document Type: Article

References (93)

1. Simmonds P, Becher P, Bukh J, Gould EA, Meyers G, Monath T, et al. ICTV Virus Taxonomy Profile: Flaviviridae. The Journal of General Virology. 2017;98(1):2–3. doi: 10.1099/jgv.0.000672 28218572
2. Perera-Lecoin M, Meertens L, Carnec X, Amara A, Flavivirus entry receptors: an update. Viruses. 2014;6(1):69–88. Epub 2014/01/02. doi: 10.3390/v6010069 24381034
3. Cruz-Oliveira C, Freire JM, Conceicao TM, Higa LM, Castanho MA, Da Poian AT, Receptors and routes of dengue virus entry into the host cells. FEMS Microbiol Rev. 2015;39(2):155–70. Epub 2015/03/01. doi: 10.1093/femsre/fuu004 25725010.
4. Smit JM, Moesker B, Rodenhuis-Zybert I, Wilschut J, Flavivirus cell entry and membrane fusion. Viruses. 2011;3(2):160–71. Epub 2011/11/04. doi: 10.3390/v3020160 22049308
5. Amara A, Mercer J, Viral apoptotic mimicry. Nat Rev Micro. 2015;13(8):461–9. doi: 10.1038/nrmicro3469 26052667
6. Miner JJ, Diamond MS, Zika virus pathogenesis and tissue tropism. Cell Host Microbe. 2017;21(2):134–42. https://doi.org/10.1016/j.chom.2017.01.004. 28182948
7. Lindenbach BD, Murray CL, Thiel HJ, Rice CM, Knipe DM, Howley PM, Cohen JI, Griffin DE, Lamb RA, Martin MA, Flaviviridae. In: et al., editors. Fields Virology. 1. 6 ed. Philadelphia: Lippincott. Williams & Wilkins.; 2013. p. 712–46.
8. Zhang Y, Corver J, Chipman PR, Zhang W, Pletnev SV, Sedlak D, et al. Structures of immature flavivirus particles. Embo J. 2003;22(11):2604–13. doi: 10.1093/emboj/cdg270 12773377.
9. Yu IM, Zhang W, Holdaway HA, Li L, Kostyuchenko VA, Chipman PR, et al. Structure of the immature dengue virus at low pH primes proteolytic maturation. Science. 2008;319(5871):1834–7. doi: 10.1126/science.1153264 18369148.
10. Kuhn RJ, Zhang W, Rossmann MG, Pletnev SV, Corver J, Lenches E, et al. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell. 2002;108(5):717–25. 11893341
11. Rey FA, Heinz FX, Mandl C, Kunz C, Harrison SC, The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature. 1995;375(6529):291–8. doi: 10.1038/375291a0 7753193.
12. Pokidysheva E, Zhang Y, Battisti AJ, Bator-Kelly CM, Chipman PR, Xiao C, et al. Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN. Cell. 2006;124(3):485–93. Epub 2006/02/14. doi: 10.1016/j.cell.2005.11.042 16469696.
13. Gollins SW, Porterfield JS, Flavivirus infection enhancement in macrophages: radioactive and biological studies on the effect of antibody on viral fate. J Gen Virol. 1984;65 (Pt 8):1261–72. Epub 1984/08/01. doi: 10.1099/0022-1317-65-8-1261 6086817.
14. Gollins SW, Porterfield JS, Flavivirus infection enhancement in macrophages: an electron microscopic study of viral cellular entry. J Gen Virol. 1985;66 (Pt 9):1969–82. Epub 1985/09/01. doi: 10.1099/0022-1317-66-9-1969 4031825.
15. Ayala-Nunez NV, Hoornweg TE, van de Pol DP, Sjollema KA, Flipse J, van der Schaar HM, et al. How antibodies alter the cell entry pathway of dengue virus particles in macrophages. Sci Rep. 2016;6:28768. Epub 2016/07/08. doi: 10.1038/srep28768 27385443
16. Dowd KA, Pierson TC, Antibody-mediated neutralization of flaviviruses: a reductionist view. Virology. 2011;411(2):306–15. Epub 2011/01/25. doi: 10.1016/j.virol.2010.12.020 21255816
17. Halstead SB, Dengue antibody-dependent enhancement: Knowns and unknowns. Microbiol Spectr. 2014;2(6). doi: 10.1128/microbiolspec.AID-0022-2014 26104444
18. Taylor A, Foo S-S, Bruzzone R, Vu Dinh L, King NJC, Mahalingam S, Fc receptors in antibody-dependent enhancement of viral infections. Immunol Rev. 2015;268(1):340–64. doi: 10.1111/imr.12367 26497532
19. Halstead SB, Biologic evidence required for Zika disease enhancement by dengue antibodies. Emerg Infect Dis. 2017;23(4):569–73. doi: 10.3201/eid2304.161879 28322690
20. Bardina SV, Bunduc P, Tripathi S, Duehr J, Frere JJ, Brown JA, et al. Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity. Science. 2017;356(6334):175. doi: 10.1126/science.aal4365 28360135
21. Screaton G, Mongkolsapaya J, Yacoub S, Roberts C, New insights into the immunopathology and control of dengue virus infection. Nat Rev Immunol. 2015;15(12):745–59. Epub 2015/11/26. doi: 10.1038/nri3916 26603900.
22. Kuhn RJ, Dowd KA, Beth Post C, Pierson TC, Shake, rattle, and roll: Impact of the dynamics of flavivirus particles on their interactions with the host. Virology. 2015;479–480:508–17. doi: 10.1016/j.virol.2015.03.025 25835729
23. Zhang X, Sheng J, Plevka P, Kuhn RJ, Diamond MS, Rossmann MG, Dengue structure differs at the temperatures of its human and mosquito hosts. Proc Natl Acad Sci U S A. 2013;110(17):6795–9. Epub 2013/04/10. doi: 10.1073/pnas.1304300110 23569243
24. Fibriansah G, Ng TS, Kostyuchenko VA, Lee J, Lee S, Wang J, et al. Structural changes in dengue virus when exposed to a temperature of 37°C. J Virol. 2013;87(13):7585–92. Epub 2013/05/03. doi: 10.1128/JVI.00757-13 23637405.
25. Lok SM, Kostyuchenko V, Nybakken GE, Holdaway HA, Battisti AJ, Sukupolvi-Petty S, et al. Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins. Nat Struct Mol Biol. 2008;15(3):312–7. doi: 10.1038/nsmb.1382 18264114.
26. Austin SK, Dowd KA, Shrestha B, Nelson CA, Edeling MA, Johnson S, et al. Structural basis of differential neutralization of DENV-1 genotypes by an antibody that recognizes a cryptic epitope. PLoS pathogens. 2012;8(10):e1002930. Epub 2012/10/12. doi: 10.1371/journal.ppat.1002930 23055922
27. Cockburn JJ, Navarro Sanchez ME, Fretes N, Urvoas A, Staropoli I, Kikuti CM, et al. Mechanism of dengue virus broad cross-neutralization by a monoclonal antibody. Structure. 2012;20(2):303–14. doi: 10.1016/j.str.2012.01.001 22285214.
28. Harrison SC, Viral membrane fusion. Virology. 2015;479–480:498–507. doi: 10.1016/j.virol.2015.03.043 25866377
29. White JM, Whittaker GR, Fusion of enveloped viruses in endosomes. Traffic. 2016;17(6):593–614. doi: 10.1111/tra.12389 26935856
30. Mori S, Takeuchi T, Kanda T, Antibody-dependent enhancement of adeno-associated virus infection of human monocytic cell lines. Virology. 2008;375(1):141–7. Epub 2008/02/26. doi: 10.1016/j.virol.2008.01.033 18295295.
31. Blaas D, Fuchs R, Mechanism of human rhinovirus infections. Mol Cell Pediatr. 2016;3(1):21. Epub 2016/06/03. doi: 10.1186/s40348-016-0049-3 27251607
32. Lonberg-Holm K, Korant BD, Early interaction of rhinoviruses with host cells. J Virol. 1972;9(1):29–40. 4333543
33. Herdy B, Snyers L, Reithmayer M, Hinterdorfer P, Blaas D, Identification of the human rhinovirus serotype 1A binding site on the murine low-density lipoprotein receptor by using human-mouse receptor chimeras. J Virol. 2004;78(13):6766–74. Epub 2004/06/15. doi: 10.1128/JVI.78.13.6766-6774.2004 15194751
34. Tassaneetrithep B, Burgess TH, Granelli-Piperno A, Trumpfheller C, Finke J, Sun W, et al. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med. 2003;197(7):823–9. doi: 10.1084/jem.20021840 12682107
35. Modhiran N, Kalayanarooj S, Ubol S, Subversion of innate defenses by the interplay between DENV and pre-existing enhancing antibodies: TLRs signaling collapse. PLoS Negl Trop Dis. 2010;4(12):e924. doi: 10.1371/journal.pntd.0000924 21200427
36. van de Winkel JG, Anderson CL, Biology of human immunoglobulin G Fc receptors. J Leukoc Biol. 1991;49(5):511–24. 1826726
37. Crill WD, Chang G-JJ, Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes. J Virol. 2004;78(24):13975–86. doi: 10.1128/JVI.78.24.13975-13986.2004 15564505
38. Stiasny K, Kiermayr S, Holzmann H, Heinz FX, Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites. J Virol. 2006;80(19):9557–68. Epub 2006/09/16. doi: 10.1128/JVI.00080-06 16973559
39. Heinz FX, Mandl CW, Holzmann H, Kunz C, Harris BA, Rey F, et al. The flavivirus envelope protein E: isolation of a soluble form from tick-borne encephalitis virus and its crystallization. J Virol. 1991;65(10):5579–83. 1716695.
40. Tsouchnikas G, Zlatkovic J, Jarmer J, Strauss J, Vratskikh O, Kundi M, et al. Immunization with immune complexes modulates the fine specificity of antibody responses to a flavivirus antigen. J Virol. 2015;89(15):7970–8. Epub 2015/05/29. doi: 10.1128/JVI.00938-15 26018152
41. Stiasny K, Kossl C, Lepault J, Rey FA, Heinz FX, Characterization of a structural intermediate of flavivirus membrane fusion. PLoS Pathog. 2007;3(2):e20. Epub 2007/02/20. doi: 10.1371/journal.ppat.0030020 17305426
42. Stiasny K, Brandler S, Kossl C, Heinz FX, Probing the flavivirus membrane fusion mechanism by using monoclonal antibodies. J Virol. 2007;81(20):11526–31. doi: 10.1128/JVI.01041-07 17670824
43. Allison SL, Schalich J, Stiasny K, Mandl CW, Heinz FX, Mutational evidence for an internal fusion peptide in flavivirus envelope protein E. J Virol. 2001;75(9):4268–75. doi: 10.1128/JVI.75.9.4268-4275.2001 11287576.
44. Cherrier MV, Kaufmann B, Nybakken GE, Lok SM, Warren JT, Chen BR, et al. Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody. EMBO J. 2009;28(20):3269–76. doi: 10.1038/emboj.2009.245 19713934
45. Corver J, Ortiz A, Allison SL, Schalich J, Heinz FX, Wilschut J, Membrane fusion activity of tick-borne encephalitis virus and recombinant subviral particles in a liposomal model system. Virology. 2000;269(1):37–46. doi: 10.1006/viro.1999.0172 10725196.
46. Stiasny K, Allison SL, Mandl CW, Heinz FX, Role of metastability and acidic pH in membrane fusion by tick-borne encephalitis virus. J Virol. 2001;75(16):7392–8. doi: 10.1128/JVI.75.16.7392-7398.2001 11462011.
47. Oliphant T, Nybakken GE, Engle M, Xu Q, Nelson CA, Sukupolvi-Petty S, et al. Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein. J Virol. 2006;80(24):12149–59. Epub 2006/10/13. doi: 10.1128/JVI.01732-06 17035317
48. Crill WD, Roehrig JT, Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells. J Virol. 2001;75(16):7769–73. doi: 10.1128/JVI.75.16.7769-7773.2001 11462053
49. Smith SA, de Alwis AR, Kose N, Jadi RS, de Silva AM, Crowe JE, Isolation of dengue virus-specific memory B cells with live virus antigen from human subjects following natural infection reveals the presence of diverse novel functional groups of antibody clones. J Virol. 2014;88(21):12233–41. doi: 10.1128/JVI.00247-14 25100837
50. Jose J, Snyder JE, Kuhn RJ, A structural and functional perspective of alphavirus replication and assembly. Future microbiology. 2009;4:837–56. doi: 10.2217/fmb.09.59 19722838
51. Flynn DC, Olmsted RA, Mackenzie JM, Johnston RE, Antibody-mediated activation of sindbis virus. Virology. 1988;166(1):82–90. http://dx.doi.org/10.1016/0042-6822(88)90149-3. 3413988
52. Dowd KA, DeMaso CR, Pierson TC, Genotypic differences in dengue virus neutralization are explained by a single amino acid mutation that modulates virus breathing. MBio. 2015;6(6):e01559–15. doi: 10.1128/mBio.01559-15 26530385
53. Goo L, VanBlargan LA, Dowd KA, Diamond MS, Pierson TC, A single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesis. PLoS Pathogens. 2017;13(2):e1006178. doi: 10.1371/journal.ppat.1006178 28207910
54. Wang C, Katzelnick LC, Montoya M, Hue KDT, Simmons CP, Harris E, Evolutionarily successful Asian 1 dengue virus 2 lineages contain one substitution in envelope that increases sensitivity to polyclonal antibody neutralization. J Infect Dis. 2016;213(6):975–84. doi: 10.1093/infdis/jiv536 26582957
55. Huang KJ, Yang YC, Lin YS, Huang JH, Liu HS, Yeh TM, et al. The dual-specific binding of dengue virus and target cells for the antibody-dependent enhancement of dengue virus infection. J Immunol. 2006;176(5):2825–32. Epub 2006/02/24. 16493039.
56. Heinz FX, Mandl C, Berger R, Tuma W, Kunz C, Antibody-induced conformational changes result in enhanced avidity of antibodies to different antigenic sites on the tick-borne encephalitis virus glycoprotein. Virology. 1984;133(1):25–34. Epub 1984/02/01. 6199892.
57. Henchal EA, McCown JM, Burke DS, Seguin MC, Brandt WE, Epitopic analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies. Am J Trop Med Hyg. 1985;34(1):162–9. 2578750
58. Mandl CW, Guirakhoo F, Holzmann H, Heinz FX, Kunz C, Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model. J Virol. 1989;63(2):564–71. 2463377.
59. Kiermayr S, Stiasny K, Heinz FX, Impact of quaternary organization on the antigenic structure of the tick-borne encephalitis virus envelope glycoprotein E. J Virol. 2009;83(17):8482–91. Epub 2009/06/26. doi: 10.1128/JVI.00660-09 19553320
60. Fibriansah G, Lok SM, The development of therapeutic antibodies against dengue virus. Antiviral Res. 2016;128:7–19. doi: 10.1016/j.antiviral.2016.01.002 26794397.
61. Fritz R, Stiasny K, Heinz FX, Identification of specific histidines as pH sensors in flavivirus membrane fusion. J Cell Biol. 2008;183(2):353–61. doi: 10.1083/jcb.200806081 18936253.
62. Schmid MA, Diamond MS, Harris E, Dendritic cells in dengue virus infection: targets of virus replication and mediators of immunity. Front Immunol. 2014;5:647. Epub 2015/01/08. doi: 10.3389/fimmu.2014.00647 25566258
63. Chambers TJ, Hahn CS, Galler R, Rice CM, Flavivirus genome organization, expression, and replication. Annu Rev Microbiol. 1990;44:649–88. Epub 1990/01/01. doi: 10.1146/annurev.mi.44.100190.003245 2174669.
64. van der Schaar HM, Rust MJ, Waarts BL, van der Ende-Metselaar H, Kuhn RJ, Wilschut J, et al. Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking. J Virol. 2007;81(21):12019–28. Epub 2007/08/31. doi: 10.1128/JVI.00300-07 17728239
65. Vratskikh O, Stiasny K, Zlatkovic J, Tsouchnikas G, Jarmer J, Karrer U, et al. Dissection of antibody specificities induced by yellow fever vaccination. PLoS Pathog. 2013;9(6):e1003458. Epub 2013/07/03. doi: 10.1371/journal.ppat.1003458 23818856.
66. Jarmer J, Zlatkovic J, Tsouchnikas G, Vratskikh O, Strauss J, Aberle JH, et al. Variation of the specificity of the human antibody responses after tick-borne encephalitis virus infection and vaccination. J Virol. 2014;88(23):13845–57. doi: 10.1128/JVI.02086-14 25253341.
67. Crill WD, Hughes HR, Delorey MJ, Chang G-JJ, Humoral immune responses of dengue fever patients using epitope-specific serotype-2 virus-like particle antigens. PLoS One. 2009;4(4):e4991. doi: 10.1371/journal.pone.0004991 19337372
68. Tsai W-Y, Durbin A, Tsai J-J, Hsieh S-C, Whitehead S, Wang W-K, Complexity of neutralizing antibodies against multiple dengue virus serotypes after heterotypic immunization and secondary infection revealed by in-depth analysis of cross-reactive antibodies. J Virol. 2015;89(14):7348–62. doi: 10.1128/JVI.00273-15 25972550
69. Xu M, Züst R, Toh YX, Pfaff JM, Kahle KM, Davidson E, et al. Protective capacity of the human anamnestic antibody response during acute dengue virus infection. J Virol. 2016;90(24):11122–31. doi: 10.1128/JVI.01096-16 27707930
70. Rogers TF, Goodwin EC, Briney B, Sok D, Beutler N, Strubel A, et al. Zika virus activates de novo and cross-reactive memory B cell responses in dengue-experienced donors. Science Immunology. 2017;2(14).
71. Rey FA, Stiasny K, Heinz FX, Flavivirus structural heterogeneity: implications for cell entry. Curr Opin Virol. 2017;24:132–9. https://doi.org/10.1016/j.coviro.2017.06.009. 28683393
72. Sallusto F, Lanzavecchia A, Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 1994;179(4):1109–18. Epub 1994/04/01. 8145033
73. Richter MK, da Silva Voorham JM, Torres Pedraza S, Hoornweg TE, van de Pol DP, Rodenhuis-Zybert IA, et al. Immature dengue virus is infectious in human immature dendritic cells via interaction with the receptor molecule DC-SIGN. PLoS One. 2014;9(6):e98785. Epub 2014/06/03. doi: 10.1371/journal.pone.0098785 24886790
74. Konradi S, Yasmin N, Haslwanter D, Weber M, Gesslbauer B, Sixt M, et al. Langerhans cell maturation is accompanied by induction of N-cadherin and the transcriptional regulators of epithelial—mesenchymal transition ZEB1/2. Eur J Immunol. 2014;44(2):553–60. doi: 10.1002/eji.201343681 24165969
75. Heinz FX, Kunz C, Homogeneity of the structural glycoprotein from European isolates of tick-borne encephalitis virus: comparison with other flaviviruses. J Gen Virol. 1981;57(Pt 2):263–74. Epub 1981/12/01. doi: 10.1099/0022-1317-57-2-263 6172553.
76. Heinz FX, Stiasny K, Puschner-Auer G, Holzmann H, Allison SL, Mandl CW, et al. Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM. Virology. 1994;198(1):109–17. Epub 1994/01/01. doi: 10.1006/viro.1994.1013 8259646.
77. Heinz FX, Berger R, Majdic O, Knapp W, Kunz C, Monoclonal antibodies to the structural glycoprotein of tick-borne encephalitis virus. Infect Immun. 1982;37(3):869–74. 6182103
78. Guirakhoo F, Heinz FX, Kunz C, Epitope model of tick-borne encephalitis virus envelope glycoprotein E: analysis of structural properties, role of carbohydrate side chain, and conformational changes occurring at acidic pH. Virology. 1989;169(1):90–9. 2466373.
79. Holzmann H, Stiasny K, York H, Dorner F, Kunz C, Heinz FX, Tick-borne encephalitis virus envelope protein E-specific monoclonal antibodies for the study of low pH-induced conformational changes and immature virions. Arch Virol. 1995;140(2):213–21. 7535997.
80. Henchal EA, Gentry MK, McCown JM, Brandt WE, Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence. Am J Trop Med Hyg. 1982;31(4):830–6. https://doi.org/10.4269/ajtmh.1982.31.830. 6285749
81. Holzmann H, Stiasny K, Ecker M, Kunz C, Heinz FX, Characterization of monoclonal antibody-escape mutants of tick-borne encephalitis virus with reduced neuroinvasiveness in mice. J Gen Virol. 1997;78 (Pt 1):31–7. Epub 1997/01/01. doi: 10.1099/0022-1317-78-1-31 9010282.
82. Stiasny K, Koessl C, Heinz FX, Involvement of lipids in different steps of the flavivirus fusion mechanism. J Virol. 2003;77(14):7856–62. doi: 10.1128/JVI.77.14.7856-7862.2003 12829825.
83. Brecher M, Schornberg KL, Delos SE, Fusco ML, Saphire EO, White JM, Cathepsin cleavage potentiates the Ebola virus glycoprotein to undergo a subsequent fusion-relevant conformational change. J Virol. 2012;86(1):364–72. doi: 10.1128/JVI.05708-11 22031933
84. Kofler RM, Hoenninger VM, Thurner C, Mandl CW, Functional analysis of the tick-borne encephalitis virus cyclization elements indicates major differences between mosquito-borne and tick-borne flaviviruses. J Virol. 2006;80(8):4099–113. doi: 10.1128/JVI.80.8.4099-4113.2006 16571826
85. Taucher C, Berger A, Mandl CW, A trans-complementing recombination trap demonstrates a low propensity of flaviviruses for intermolecular recombination. J Virol. 2010;84(1):599–611. doi: 10.1128/JVI.01063-09 19864381
86. Mandl CW, Ecker M, Holzmann H, Kunz C, Heinz FX, Infectious cDNA clones of tick-borne encephalitis virus European subtype prototypic strain Neudoerfl and high virulence strain Hypr. J Gen Virol. 1997;78:1049–57. doi: 10.1099/0022-1317-78-5-1049 9152422.
87. Duechler M, Skern T, Blaas D, Berger B, Sommergruber W, Kuechler E, Human rhinovirus serotype 2: in vitro synthesis of an infectious RNA. Virology. 1989;168(1):159–61. 2535899.
88. Blazevic J, Rouha H, Bradt V, Heinz FX, Stiasny K, Membrane anchors of the structural flavivirus proteins and their role in virus assembly. J Virol. 2016;90(14):6365–78. doi: 10.1128/JVI.00447-16 27147734.
89. Allison SL, Schalich J, Stiasny K, Mandl CW, Kunz C, Heinz FX, Oligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pH. J Virol. 1995;69(2):695–700. 7529335.
90. Maizel JV, JrPolyacrylamide gel electrophoresis of viral proteins. Methods Virol. 1971;5:179–246.
91. Schalich J, Allison SL, Stiasny K, Mandl CW, Kunz C, Heinz FX, Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions. J Virol. 1996;70(7):4549–57. 8676481.
92. Stiasny K, Aberle JH, Chmelik V, Karrer U, Holzmann H, Heinz FX, Quantitative determination of IgM antibodies reduces the pitfalls in the serodiagnosis of tick-borne encephalitis. J Clin Virol. 2012;54(2):115–20. Epub 2012/03/17. doi: 10.1016/j.jcv.2012.02.016 22421535.
93. Zlatkovic J, Tsouchnikas G, Jarmer J, Koessl C, Stiasny K, Heinz FX, Aluminum hydroxide influences not only the extent but also the fine specificity and functional activity of antibody responses to tick-borne encephalitis virus in mice. J Virol. 2013;87(22):12187–95. Epub 2013/09/06. doi: 10.1128/JVI.01690-13 24006434.